Samil Pharmaceutical recorded one insider purchase during the past ninety days. Yong Hwan Sam acquired shares valued at 15,857,140 KRW on October 12, 2026. This activity coincides with a 32.1% stock price increase over the same period, occurring amidst a lack of recent earnings report data.